XCLUSIV
Xellia Pharmaceuticals ApS
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87920033 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Danielle I. Mattessich |
| Attorney Name | Nicole K. McLaughlin |
| Attorney Docket Number | U3375-00004 |
| Law Office Assigned | N50 |
| Employee Name | HALMEN, KATHERINE E |
Timeline
| 2018-05-14 | Application Filed |
| 2018-10-23 | Published for Opposition |
| 2018-12-18 | Location: INTENT TO USE SECTION |
| 2019-06-10 | Status: Live/Pending |
| 2019-12-18 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Xellia Pharmaceuticals ApS |
| Address | Dalslandsgade 11 Copenhagen S DK DK2300 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DK |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Anti-infective, injectable pharmaceutical products in liquid finished dosage form for use in hospitals and clinics or by home health care professionals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2018-05-17 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-05-21 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-09-05 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-09-12 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-10-03 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-10-23 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-10-23 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-12-18 | 8 NOAM E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-06-10 | 9 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-06-10 | 10 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2019-06-10 | 11 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-06-10 | 12 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-06-10 | 13 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-12 | 14 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2020-01-20 | 15 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2020-01-21 | 16 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 XCLUSIV 97439336 not registered Live/Pending |
Brown, Christopher 2022-06-02 |
 XCLUSIV 97230862 not registered Live/Pending |
Habtamu B. Abere 2022-01-20 |
 XCLUSIV 87920033 not registered Live/Pending |
Xellia Pharmaceuticals ApS 2018-05-14 |
 XCLUSIV 77185256 3573308 Dead/Cancelled |
YANG, BEN 2007-05-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 